Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Medication
Muscarinic Myth Busters: Addressing Misconceptions of Muscarinic Receptor Activation in Schizophrenia
Medication
Of Musc and Men: The Exciting Potential of Muscarinic Receptor Modulation in the Treatment of Schizophrenia
Medication
Focus on Psychosis: Integrating Therapeutic Advances in the Treatment of Positive Symptoms of Schizophrenia
Medication
A New Frontier in Schizophrenia: Muscarinic Modulators and Their Role in Treatment
Medication
Advancing Schizophrenia Care: Improving Outcomes with Muscarinic Modulators
Providers discussing
Why Should We Deprescribe Anticholinergics?
Patient medication
Patient Concerns About Deprescribing: How to Address Them
Patient and psychologist
How to Taper Anticholinergic Medications Safely
Brain image
Are There Guidelines for Deprescribing Anticholinergics?
Patient in counseling
Patient Case Studies: Successful Deprescription of Anticholinergics

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy